Health GLP-1RAs Reduce Cardiovascular & Kidney Risks in Type 1 Diabetes: A Target Trial Emulation Study by Grace Chen March 22, 2026 written by Grace Chen March 22, 2026 86 Related BiomedicineCancer ResearchgeneralInfectious diseasesMetabolic DiseasesMolecular MedicineNeurosciences 0 comments 0 FacebookTwitterPinterestEmail Grace Chen Board-certified physician and medical writer. Translates research into practical health advice and public-health coverage. previous post ICE at Airports: Trump Plan Sparks Shutdown Fight & Security Concerns next post Rams 2026 NFL Draft: Adding to a Super Bowl-Contending Roster You may also like CDC Warns of Summer Spike in Rabies Exposures September 11, 2026 Toilet Flushing Spreads Germs Up to 5 Feet... September 11, 2026 Girls’ Suicide Rates Equal Those of Boys in... September 11, 2026 Seattle CEOs Demand 100-Day Public Safety Action Plan... September 11, 2026 Nighttime Light Exposure Linked to Subtle Changes in... September 11, 2026 Understanding Shiga Toxin Producing E Coli and Cattle... September 10, 2026 VolitionRx Showcases Capture-Seq Tech for Early Cancer Detection September 10, 2026 US Alcohol-Linked Cancer Deaths More Than Doubled Since... September 10, 2026 US Ectopic Pregnancy Deaths Nearly Double, Rising Most... September 10, 2026 FIU Researcher Defines Mathematical Cure Threshold for Lung... September 10, 2026 Leave a Comment Cancel Reply Notify me of follow-up comments by email. Notify me of new posts by email. Δ
